CN1234400C - Medicine for treating viral hepatitis B - Google Patents
Medicine for treating viral hepatitis B Download PDFInfo
- Publication number
- CN1234400C CN1234400C CN 200410005714 CN200410005714A CN1234400C CN 1234400 C CN1234400 C CN 1234400C CN 200410005714 CN200410005714 CN 200410005714 CN 200410005714 A CN200410005714 A CN 200410005714A CN 1234400 C CN1234400 C CN 1234400C
- Authority
- CN
- China
- Prior art keywords
- herba
- shares
- medicine
- mass fraction
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating viral hepatitis B, particularly to the technical field of the medicine for treating viral hepatitis B prepared from Chinese herbal medicines. The medicine for treating viral hepatitis B needs to solve the technical problem that the negative transform rate of hepatitis B virus surface antigen of the patient is not increased, and the patients can not recuperate health. The present invention adopts a technical scheme for solving the technical problems: decoctions or granules are processed by a conventional pharmacy technology by medicaments manufactured by the raw materials of the medicine for treating viral hepatitis B by the following weight parts: 1 to 5 shares of european verbena, 3 to 9 shares of swollen furuncle, 1 to 5 shares of spica prunellae, 5 to 13 shares of common clubmoss herb, 1 to 5 shares of melic grass, 3 to 9 shares of asiatic pennywort herb, 5 to 13 shares of lesser hypericum, 1 to 5 shares of elephantopus, 7 to 17 shares of cape jasmine fruit, 4 to 11 shares of indian kalimeris herb, 6 to 15 shares of oldenlandia and 1 to 5 shares of plantain herb. The present invention has the advantages of easy acquirement of raw material source and convenient administration of medicine patients. The present invention can make the negative transform rate of hepatitis B virus surface antigen (HBsAg) of small third-yang hepatitis patients or big third-yang hepatitis patients be over 90%.
Description
Technical field: the present invention relates to a kind of medicine for the treatment of hepatitis B, particularly a kind of technical field that becomes the medicine of treatment Type B viral hepatitis with prepared from traditional Chinese medicines.
Background technology: hepatitis, particularly Type B viral hepatitis are a kind of difficult healings and infect the infectious disease of giving other people especially easily that at present, no matter the traditional Chinese medical science still is doctor trained in Western medicine is not all had specific drug to this.In many medicines of present stage treatment hepatitis B, use more a kind of interferon, even use interferon, still be difficult to eliminate the carrier state of hepatitis B surface antigen (HBsAg), cause some Type B viral hepatitis patients to develop into liver cirrhosis even hepatocarcinoma, cause very big injury for patient and family thereof.
Summary of the invention: technical problem to be solved by this invention provides a kind of negative conversion rate that can overcome above-mentioned defective, hepatitis B surface antigen and reaches more than 90%, improves symptom, sign and liver function, has the hepatitis B virus of killing, promotes liver cell regeneration, strengthens liver immunity, reduce chronic type B viral hepatitis and transform, finally make the medicine of the restorative treatment Type B viral hepatitis of patient to liver cirrhosis even hepatocarcinoma.The technical scheme that solves this technical problem employing is: a kind of medicine for the treatment of Type B viral hepatitis, it is characterized in that it is by Herba Verbenae, Caulis et folium pavettae hongkongensis, Spica Prunellae, Herba Lycopodii, Herba Melicae Scabrosae, Herba Centellae, Herba Hyperici Japonici, Elephantopus scaber L., Fructus Gardeniae, Herba Kalimeridis, Herba Hedyotidis Diffusae, Herba Plantaginis, the medicament of making by the raw material of following mass fraction combination, wherein the shared mass fraction of Herba Verbenae is 1-5, the shared mass fraction of Caulis et folium pavettae hongkongensis is 3-9, the shared mass fraction of Spica Prunellae is 1-5, the shared mass fraction of Herba Lycopodii is 5-13, the shared mass fraction of Herba Melicae Scabrosae is 1-5, the shared mass fraction of Herba Centellae is 3-9, the shared mass fraction of Herba Hyperici Japonici is 5-13, the shared mass fraction of Elephantopus scaber L. is 1-5, the shared mass fraction of Fructus Gardeniae is 7-17, the shared mass fraction of Herba Kalimeridis is 4-11, the shared mass fraction of Herba Hedyotidis Diffusae is 6-15, the shared mass fraction of Herba Plantaginis is 1-5, and this drug agents is said arbitrary dosage form on the pharmaceutics.When the mass fraction of Herba Verbenae, Caulis et folium pavettae hongkongensis, Spica Prunellae, Herba Lycopodii, Herba Melicae Scabrosae, Herba Centellae, Herba Hyperici Japonici, Elephantopus scaber L., Fructus Gardeniae, Herba Kalimeridis, Herba Hedyotidis Diffusae, Herba Plantaginis was respectively 2,4,2,6,2,4,6,2,8,5,7,2, made decoction was mainly used in the Type B viral hepatitis patient of treatment small three positive; When the mass fraction of Herba Verbenae, Caulis et folium pavettae hongkongensis, Spica Prunellae, Herba Lycopodii, Herba Melicae Scabrosae, Herba Centellae, Herba Hyperici Japonici, Elephantopus scaber L., Fructus Gardeniae, Herba Kalimeridis, Herba Hedyotidis Diffusae, Herba Plantaginis was respectively 4,8,4,12,4,8,12,4,16,10,14,4, made decoction was mainly used in the Type B viral hepatitis patient of treatment great three positive.The present invention compared with prior art has following beneficial effect: 1. the present invention constitutes simply, and raw materials for production are easy to get, and all adopts natural Chinese medicinal herb; 2. production method of the present invention is simple, and cost is low; 3. patient's taking convenience, safe and reliable, short treating period, effect is remarkable, and clinical practice shows that the negative conversion rate of patient's hepatitis B surface antigen (HBsAg) reaches more than 90%.4. the present invention also has good therapeutic effect to the viral hepatitis of other type.
The specific embodiment: embodiment 1 is the medicine of treatment Type B viral hepatitis (small three positive), with Herba Verbenae, Caulis et folium pavettae hongkongensis, Spica Prunellae, Herba Lycopodii, Herba Melicae Scabrosae, Herba Centellae, Herba Hyperici Japonici, Elephantopus scaber L., Fructus Gardeniae, Herba Kalimeridis, Herba Hedyotidis Diffusae, the dried Chinese herbal medicine of Herba Plantaginis, with the gram is that unit gets 2 respectively, 4,2,6,2,4,6,2,8,5,7,2 grams, add water 800 to 900 grams, decocting adds white sugar 20 grams after boiling into decoction, use for three taking medicine before meal of patient's one bu, through one, two courses of treatment, be can reach a therapeutic effect in month each course of treatment, and promptly hepatitis B surface antigen (HBsAg) negative conversion rate reaches more than 90%.Embodiment 2 is the medicine of treatment Type B viral hepatitis (great three positive), with Herba Verbenae, Caulis et folium pavettae hongkongensis, Spica Prunellae, Herba Lycopodii, Herba Melicae Scabrosae, Herba Centellae, Herba Hyperici Japonici, Elephantopus scaber L., Fructus Gardeniae, Herba Kalimeridis, Herba Hedyotidis Diffusae, the dried Chinese herbal medicine of Herba Plantaginis, with the gram is that unit gets 4 respectively, 8,4,12,4,8,12,4,16,10,14,4 grams, add water 800 to 900 grams, decocting adds white sugar 20 grams after boiling into decoction, use for three taking medicine before meal of patient's one bu, through one, two, three courses of treatment, be one month each course of treatment, can reach therapeutic effect, promptly hepatitis B surface antigen (HBsAg) negative conversion rate reaches more than 90%.Show that through clinical practice the present invention constitutes simply, raw material is easy to get, and all adopts natural Chinese medicinal herb, and production method is simple, and cost is low, patient's taking convenience, safe and reliable, short treating period, effect is remarkable, and the negative conversion rate of patient's hepatitis B surface antigen (HBsAg) reaches more than 90%.
Description of drawings: Fig. 1 is that figure is xeroxed in the whole strain of the grass medicine of " Caulis et folium pavettae hongkongensis " of the present invention.
Claims (3)
1, a kind of medicine for the treatment of Type B viral hepatitis, it is characterized in that it is by Herba Verbenae, Caulis et folium pavettae hongkongensis, Spica Prunellae, Herba Lycopodii, Herba Melicae Scabrosae, Herba Centellae, Herba Hyperici Japonici, Elephantopus scaber L., Fructus Gardeniae, Herba Kalimeridis, Herba Hedyotidis Diffusae, the medicament that Herba Plantaginis is made by the raw material of following mass fraction combination, wherein the shared mass fraction of Herba Verbenae is 1-5, the shared mass fraction of Caulis et folium pavettae hongkongensis is 3-9, the shared mass fraction of Spica Prunellae is 1-5, the shared mass fraction of Herba Lycopodii is 5-13, the shared mass fraction of Herba Melicae Scabrosae is 1-5, the shared mass fraction of Herba Centellae is 3-9, the shared mass fraction of Herba Hyperici Japonici is 5-13, the shared mass fraction of Elephantopus scaber L. is 1-5, the shared mass fraction of Fructus Gardeniae is 7-17, the shared mass fraction of Herba Kalimeridis is 4-11, the shared mass fraction of Herba Hedyotidis Diffusae is 6-15, the shared mass fraction of Herba Plantaginis is 1-5.
2, a kind of medicine for the treatment of Type B viral hepatitis according to claim 1 is characterized in that wherein the mass fraction of Herba Verbenae, Caulis et folium pavettae hongkongensis, Spica Prunellae, Herba Lycopodii, Herba Melicae Scabrosae, Herba Centellae, Herba Hyperici Japonici, Elephantopus scaber L., Fructus Gardeniae, Herba Kalimeridis, Herba Hedyotidis Diffusae, Herba Plantaginis is respectively 2,4,2,6,2,4,6,2,8,5,7,2.
3, a kind of medicine for the treatment of Type B viral hepatitis according to claim 1 is characterized in that wherein the mass fraction of Herba Verbenae, Caulis et folium pavettae hongkongensis, Spica Prunellae, Herba Lycopodii, Herba Melicae Scabrosae, Herba Centellae, Herba Hyperici Japonici, Elephantopus scaber L., Fructus Gardeniae, Herba Kalimeridis, Herba Hedyotidis Diffusae, Herba Plantaginis is respectively 4,8,4,12,4,8,12,4,16,10,14,4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410005714 CN1234400C (en) | 2004-02-18 | 2004-02-18 | Medicine for treating viral hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410005714 CN1234400C (en) | 2004-02-18 | 2004-02-18 | Medicine for treating viral hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1559463A CN1559463A (en) | 2005-01-05 |
| CN1234400C true CN1234400C (en) | 2006-01-04 |
Family
ID=34439670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410005714 Expired - Fee Related CN1234400C (en) | 2004-02-18 | 2004-02-18 | Medicine for treating viral hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1234400C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784366B (en) * | 2012-09-03 | 2013-07-31 | 赵全成 | Medical composition with function of decanting and protecting liver |
| CN114796233A (en) * | 2022-06-17 | 2022-07-29 | 重庆医科大学国际体外诊断研究院 | Application of asiatic acid in preparing medicine for treating hepatitis B |
-
2004
- 2004-02-18 CN CN 200410005714 patent/CN1234400C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1559463A (en) | 2005-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1076120A (en) | Medical liquid for relaxing tendons and joints | |
| CN101134085A (en) | Traditional Chinese medicine for treating apoplexy and hemiplegia | |
| CN1047090C (en) | Plaster for curing cough with dyspnea | |
| CN1546066A (en) | Gastrointestinal ulcer treating Chinese traditional medicine | |
| CN1270765C (en) | Medicinal wine or liquid for treating cold | |
| CN101732403A (en) | Chinese medicament for treating muguet | |
| CN1234400C (en) | Medicine for treating viral hepatitis B | |
| CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
| CN1161840A (en) | Medicine for making four-seasons tea for treating cold and preparation technology thereof | |
| CN1100642A (en) | Traditional Chinese medicine prepn. for curing B-hepatitis | |
| CN103690922B (en) | A kind of Chinese medicine composition and application for the treatment of polycystic ovarian syndrome | |
| CN103861031A (en) | Traditional Chinese medicine for treating chronic superficial gastritis | |
| CN1356124A (en) | Medicine for treating hepatism | |
| CN1292275A (en) | Chinese medicine preparation for curing postpartum disease of woman | |
| CN101007113B (en) | Shenling Chinese medicine preparation for treating acute and chronic hepatitis and its preparation method | |
| CN1333026A (en) | Medicine for treating hyperplasia of mammary glands | |
| CN1022165C (en) | Preparation and process of oral medicinal liquid for recuperating blood vessels | |
| CN101278982A (en) | Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same | |
| CN103705829B (en) | A kind of medicine for the treatment of hepatopathy | |
| CN1404847A (en) | Medicine for treating sequel resulted from cardio-cerebral blood-vessel diseases | |
| CN1091026A (en) | Danshixiao medicine for treating cholelithiasis | |
| CN1235840A (en) | Chinese medicine powder for curing rheumatoid and rheumatic diseases | |
| CN1137697C (en) | Compound medicinal powder for treating tuberculosis | |
| CN105362999A (en) | Traditional Chinese medicine preparation for preventing and treating infantile repeated cold and preparation method thereof | |
| CN106362034A (en) | Medicine for treating constitution of qi stagnation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060104 |